VRTX fundamentals
An in-depth look to VERTEX PHARMACEUTICAL operating, investing, and financing activities
VRTX free cash flow for Q2 24 is -70.11 B MXN. For 2023, VRTX free cash flow was 56.68 B MXN and operating cash flow was 60.08 B MXN.
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: MXN
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM